Skip to Content

Lasofoxifene

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G03XC03

CAS registry number (Chemical Abstracts Service)

0180916-16-9

Chemical Formula

C28-H31-N-O2

Molecular Weight

413

Therapeutic Categories

Treatment of osteoporosis

Antineoplastic agent

Selective estrogen receptor modulator (SERM)

Chemical Names

(-)-cis-5,6,7,8-tetrahydro-6-phenyl-5-[p-[2-(1-pyrrolidinyl)etoxy]phenyl]-2-naphtol (WHO)

rel-(1R,2S)-2-Phenyl-1-{4-[2-(pyrrolidin-1-yl)etoxy]phenyl}-1,2,3,4-tetrahydro-5-naphtol (IUPAC)

Foreign Names

  • Lasofoxifenum (Latin)
  • Lasofoxifen (German)
  • Lasofoxif√®ne (French)
  • Lasofoxifeno (Spanish)

Generic Names

  • Lasofoxifene (OS: BAN)
  • CP 336156 (IS)
  • UNII-337G83N988 (IS)
  • Lasofoxifene Tartrate (OS: USAN, JAN, BANM)
  • CP-336,156-CB (IS)
  • Lasofoxifene (-)-D-tartrate (IS)
  • Lasofoxifene [(S,S)-tartrate] (IS)
  • UNII-85X09V2GSO (IS)

Brand Names

  • Fablyn
    Pfizer, Lithuania; Pfizer, Portugal

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide